Go Pro
CVE:IBT

IBEX Technologies (IBT) Stock Price, News & Analysis

C$1.44 0.00 (0.00%)
As of 04/5/2024

About IBEX Technologies Stock (CVE:IBT)

Key Stats

Today's Range
C$1.44
C$1.44
50-Day Range
C$1.44
C$1.44
52-Week Range
C$0.75
C$1.45
Volume
200 shs
Average Volume
68,888 shs
Market Capitalization
C$35.54 million
P/E Ratio
11.52
Dividend Yield
3.11%
Price Target
N/A
Consensus Rating
N/A

Company Overview

IBEX Technologies Inc., through its subsidiaries, manufactures and markets enzymes for biomedical use in Canada, the United States, Germany, the United Kingdom, and internationally. It offers a portfolio of recombinant glycosaminoglycan lyases, including Heparinase I, Heparinase II, Heparinase III, Chondroitinase AC, and Chondroitinase B; collagen ELISAs for the study of synthesis and degradation of connective tissue components; collagen antibodies; and diamine oxidase liquid. The company also manufactures and markets a range of arthritis assays, which are used in osteoarthritis research. In addition, it provides lyophilization services for making disposable medical device components; and custom fermentation and contract manufacturing services. It serves manufacturers of medical devices, quality control labs, low molecular weight heparin manufacturers, and academic research institutions. IBEX Technologies Inc. was incorporated in 1972 and is based in Montreal, Canada.

Receive IBT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for IBEX Technologies and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

IBT Stock News Headlines

IBEX Announces Record First Quarter of Fiscal Year 2025 Financial Results
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Trump has issued emergency support to accelerate the rollout, and it's already live in multiple states. The Financial Times reports Sam Altman is personally calling people to build this for OpenAI. A few little-known companies control the entire supply chain - meaning anyone who wants access must go through them. Their stocks are available to buy right now.tc pixel
ibex Launches Wave iX Translate
IBEX Completes Sale of the Company
IBEX Technologies Inc.
See More Headlines

IBT Stock Analysis - Frequently Asked Questions

IBEX Technologies' stock was trading at C$1.44 at the beginning of the year. Since then, IBT shares have increased by 0.0% and is now trading at C$1.44.

Shares of IBT stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

Based on aggregate information from My MarketBeat watchlists, some other companies that IBEX Technologies investors own include Aurora Cannabis (ACB), Acerus Pharmaceuticals (TRLPF), Air Canada (AC), American Airlines Group (AAL), Cognex (CGNX), Baytex Energy (BTE) and Bank of Montreal (BMO).

Industry, Sector and Symbol

Stock Exchange
CVE
Industry
Biotechnology
Sub-Industry
Biotechnology
Current Symbol
CVE:IBT
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
C$0.12
Trailing P/E Ratio
11.52
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
C$3.10 million
Net Margins
51.97%
Pretax Margin
N/A
Return on Equity
33.34%
Return on Assets
6.42%

Debt

Debt-to-Equity Ratio
12.05
Current Ratio
5.69
Quick Ratio
4.93

Sales & Book Value

Annual Sales
C$5.77 million
Price / Sales
6.15
Cash Flow
C$0.92 per share
Price / Cash Flow
1.56
Book Value
C$0.55 per share
Price / Book
2.62

Miscellaneous

Outstanding Shares
24,677,792
Free Float
N/A
Market Cap
C$35.54 million
Optionable
Not Optionable
Beta
-0.05
10 Best Stocks to Own - Summer 2026 Cover

Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Summer 2026, despite the threat of tariffs and what's happening in Iran. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

This page (CVE:IBT) was last updated on 8/17/2026 by MarketBeat.com Staff.
From Our Partners